PAMU
IMVT icon

Pictet Asset Management (UK)’s Immunovant IMVT Stock Holding History

Pictet Asset Management (UK)’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-405,786
Closed -$18.7M – 1819
2020
Q4 		$18.7M Sell
405,786
-910,872
-69% -$42.1M 0.02% 493
2020
Q3 		$46.3M Buy
1,316,658
+223,382
+20% +$6.72M 0.07% 281
2020
Q2 		$26.6M Buy
+1,093,276
New +$23.4M 0.05% 347

Other funds holding IMVT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
AGM
Alpine Global Management New York $615M AUM 34.28% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Pictet Asset Management (UK)'s IMVT Position: Q1 2021 in Review

Pictet Asset Management (UK) sold out of Immunovant (IMVT) in Q1 2021, closing a stake of 405,786 shares — an estimated $18.7M sold.

Pictet Asset Management (UK) first reported a position in IMVT in Q2 2020 and held it in 3 quarters. The position peaked at $46.3M in Q3 2020. 120 funds tracked by Wall St. Rank hold IMVT as of Q1 2021.

  • Pictet Asset Management (UK) reported no remaining Immunovant position as of Q1 2021 after selling out during the quarter.
  • Pictet Asset Management (UK) sold 405,786 Immunovant shares in Q1 2021, an estimated $18.7M.
  • Pictet Asset Management (UK) first reported a position in Immunovant in Q2 2020 and held it in 3 quarters.
  • Pictet Asset Management (UK)'s Immunovant position peaked at $46.3M in Q3 2020.
  • 120 funds tracked by Wall St. Rank held Immunovant as of Q1 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q1 2021, filed 17 May 2021.